Literature DB >> 31004524

Impaired Chylomicron Assembly Modifies Hepatic Metabolism Through Bile Acid-Dependent and Transmissible Microbial Adaptations.

Yan Xie1, Hitoshi Matsumoto1, Susan Kennedy1, Elizabeth P Newberry1, William Moritz1, Brian J DeBosch2, Kelle H Moley3, Deborah C Rubin1, Brad W Warner4, Andrew L Kau1, Phillip I Tarr2, Todd N Wylie2,5, Kristine M Wylie2,5, Nicholas O Davidson1.   

Abstract

The mechanisms by which alterations in intestinal bile acid (BA) metabolism improve systemic glucose tolerance and hepatic metabolic homeostasis are incompletely understood. We examined metabolic adaptations in mice with conditional intestinal deletion of the abetalipoproteinemia (ABL) gene microsomal triglyceride transfer protein (Mttp-IKO), which blocks chylomicron assembly and impairs intestinal lipid transport. Mttp-IKO mice exhibit improved hepatic glucose metabolism and augmented insulin signaling, without weight loss. These adaptations included decreased BA excretion, increased pool size, altered BA composition, and increased fibroblast growth factor 15 production. Mttp-IKO mice absorb fructose normally but are protected against dietary fructose-induced hepatic steatosis, without weight loss or changes in energy expenditure. In addition, Mttp-IKO mice exhibit altered cecal microbial communities, both at baseline and following fructose feeding, including increased abundance of Bacteroides and Lactobacillus genera. Transplantation of cecal microbiota from chow-fed Mttp-IKO mice into antibiotic-treated wild-type recipients conferred transmissible protection against fructose-induced hepatic steatosis in association with a bloom in Akkermansia and increased Clostridium XIVa genera, whose abundance was positively correlated with fecal coprostanol and total neutral sterol excretion in recipient mice. However, antibiotic-treated Mttp-IKO mice were still protected against fructose-induced hepatic steatosis, suggesting that changes in microbiota are not required for this phenotype. Nevertheless, we found increased abundance of fecal Akkermansia from two adult ABL subjects with MTTP mutations compared to their heterozygous parents and within the range noted in six healthy control subjects. Furthermore, Akkermansia abundance across all subjects was positively correlated with fecal coprostanol excretion.
Conclusion: The findings collectively suggest multiple adaptive pathways of metabolic regulation following blocked chylomicron assembly, including shifts in BA signaling and altered microbial composition that confer a transmissible phenotype.
© 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31004524      PMCID: PMC6783349          DOI: 10.1002/hep.30669

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  49 in total

1.  Differences in Alimentary Glucose Absorption and Intestinal Disposal of Blood Glucose After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.

Authors:  Jean-Baptiste Cavin; Anne Couvelard; Rachida Lebtahi; Robert Ducroc; Konstantinos Arapis; Eglantine Voitellier; Françoise Cluzeaud; Laura Gillard; Muriel Hourseau; Nidaa Mikail; Lara Ribeiro-Parenti; Nathalie Kapel; Jean-Pierre Marmuse; André Bado; Maude Le Gall
Journal:  Gastroenterology       Date:  2015-10-23       Impact factor: 22.682

2.  Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice.

Authors:  Jan Freark de Boer; Marleen Schonewille; Marije Boesjes; Henk Wolters; Vincent W Bloks; Trijnie Bos; Theo H van Dijk; Angelika Jurdzinski; Renze Boverhof; Justina C Wolters; Jan A Kuivenhoven; Jan M van Deursen; Ronald P J Oude Elferink; Antonio Moschetta; Claus Kremoser; Henkjan J Verkade; Folkert Kuipers; Albert K Groen
Journal:  Gastroenterology       Date:  2017-01-05       Impact factor: 22.682

3.  A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.

Authors:  Hubert Plovier; Amandine Everard; Céline Druart; Clara Depommier; Matthias Van Hul; Lucie Geurts; Julien Chilloux; Noora Ottman; Thibaut Duparc; Laeticia Lichtenstein; Antonis Myridakis; Nathalie M Delzenne; Judith Klievink; Arnab Bhattacharjee; Kees C H van der Ark; Steven Aalvink; Laurent O Martinez; Marc-Emmanuel Dumas; Dominique Maiter; Audrey Loumaye; Michel P Hermans; Jean-Paul Thissen; Clara Belzer; Willem M de Vos; Patrice D Cani
Journal:  Nat Med       Date:  2016-11-28       Impact factor: 53.440

4.  Compensatory increase in hepatic lipogenesis in mice with conditional intestine-specific Mttp deficiency.

Authors:  Yan Xie; Elizabeth P Newberry; Stephen G Young; Sylvie Robine; Robert L Hamilton; Jinny S Wong; Jianyang Luo; Susan Kennedy; Nicholas O Davidson
Journal:  J Biol Chem       Date:  2005-12-13       Impact factor: 5.157

5.  Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology.

Authors:  Maria Carlota Dao; Amandine Everard; Judith Aron-Wisnewsky; Nataliya Sokolovska; Edi Prifti; Eric O Verger; Brandon D Kayser; Florence Levenez; Julien Chilloux; Lesley Hoyles; Marc-Emmanuel Dumas; Salwa W Rizkalla; Joel Doré; Patrice D Cani; Karine Clément
Journal:  Gut       Date:  2015-06-22       Impact factor: 23.059

6.  Lack of liver steatosis in germ-free mice following hypercaloric diets.

Authors:  Valentina Kaden-Volynets; Marijana Basic; Ulrike Neumann; Dominik Pretz; Andreas Rings; André Bleich; Stephan C Bischoff
Journal:  Eur J Nutr       Date:  2018-06-20       Impact factor: 5.614

7.  Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia.

Authors:  Rebecca A Haeusler; Matthew Pratt-Hyatt; Carrie L Welch; Curtis D Klaassen; Domenico Accili
Journal:  Cell Metab       Date:  2011-12-22       Impact factor: 27.287

8.  Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.

Authors:  Anuradha Rao; Astrid Kosters; Jamie E Mells; Wujuan Zhang; Kenneth D R Setchell; Angelica M Amanso; Grace M Wynn; Tianlei Xu; Brad T Keller; Hong Yin; Sophia Banton; Dean P Jones; Hao Wu; Paul A Dawson; Saul J Karpen
Journal:  Sci Transl Med       Date:  2016-09-21       Impact factor: 17.956

9.  The effect of a bile acid sequestrant on glucose metabolism in subjects with type 2 diabetes.

Authors:  Galina Smushkin; Matheni Sathananthan; Francesca Piccinini; Chiara Dalla Man; Jennie H Law; Claudio Cobelli; Alan R Zinsmeister; Robert A Rizza; Adrian Vella
Journal:  Diabetes       Date:  2012-12-18       Impact factor: 9.461

10.  Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice.

Authors:  Lili Ding; Kyle M Sousa; Lihua Jin; Bingning Dong; Byung-Wook Kim; Ricardo Ramirez; Zhenzhou Xiao; Ying Gu; Qiaoling Yang; Jie Wang; Donna Yu; Alessio Pigazzi; Dustin Schones; Li Yang; David Moore; Zhengtao Wang; Wendong Huang
Journal:  Hepatology       Date:  2016-07-25       Impact factor: 17.425

View more
  5 in total

1.  Fecal microbiome and bile acid metabolome in adult short bowel syndrome.

Authors:  Harold J Boutte; Jacqueline Chen; Todd N Wylie; Kristine M Wylie; Yan Xie; Mackenzie Geisman; Anirudh Prabu; Vered Gazit; Phillip I Tarr; Marc S Levin; Brad W Warner; Nicholas O Davidson; Deborah C Rubin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-11-24       Impact factor: 4.052

2.  Environmentally Acquired Bacillus and Their Role in C. difficile Colonization Resistance.

Authors:  William T Ferreira; Huynh A Hong; James R G Adams; Mateusz Hess; Natalia K Kotowicz; Sisareuth Tan; Enrico Ferrari; Alain Brisson; Jurgen Zentek; Mikhail Soloviev; Simon M Cutting
Journal:  Biomedicines       Date:  2022-04-19

3.  Ceramide Salvage, Gut Mucosal Immunoglobulin A Signaling, and Diet-Induced NASH.

Authors:  Scott A McHenry; Nicholas O Davidson
Journal:  Hepatology       Date:  2021-02-26       Impact factor: 17.425

Review 4.  Intestinal Population in Host with Metabolic Syndrome during Administration of Chitosan and Its Derivatives.

Authors:  Chen Yan; Cuili Zhang; Xuejiao Cao; Bin Feng; Xinli Li
Journal:  Molecules       Date:  2020-12-11       Impact factor: 4.411

Review 5.  Investigating causality with fecal microbiota transplantation in rodents: applications, recommendations and pitfalls.

Authors:  Cassandra E Gheorghe; Nathaniel L Ritz; Jason A Martin; Hannah R Wardill; John F Cryan; Gerard Clarke
Journal:  Gut Microbes       Date:  2021 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.